Regulations.gov document
Interim response from FDA CDER to Encore Dermatology, Inc.
Other · FDA-2020-P-2212 · posted May 12, 2021
Key facts
| Document ID | FDA-2020-P-2212-0051 |
|---|---|
| Title | Interim response from FDA CDER to Encore Dermatology, Inc. |
| Document type | Other |
| Subtype | Response(s) |
| Agency | FDA |
| Docket | FDA-2020-P-2212 |
| Posted | May 12, 2021 |
| Comment period opens | May 12, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: